Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men with Benign Prostatic Hyperplasia Symptoms

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849258) titled 'A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men with Benign Prostatic Hyperplasia Symptoms' on Feb. 17.

Brief Summary: The goal of this study is to determine the safety and effectiveness of the FloStent, a medical device used to treat men with symptoms of Benign Prostatic Hyperplasia, compared to sham (procedure without deployment of the FloStent). All participants will undergo a flexible cystoscopy and those randomized to the treatment arm will receive the FloStent, while those randomized to the sham arm will not receive the FloStent.

Study Start Date: Feb. 10

Study Type: INTERVENTIONAL

Condition: Be...